Spectrum of mutations in the CFTR gene in cystic fibrosis patients of Spanish ancestry, Ann. Hum. Genet, vol.71, pp.22132-22140, 2007. ,
Molecular modelling and molecular dynamics of CFTR, Cell. Mol. Life Sci, vol.74, pp.3-22, 2017. ,
The implications of CFTR structural studies for cystic fibrosis drug development, Curr. Opin. Pharmacol, vol.34, pp.112-118, 2017. ,
Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis, Cell, vol.63, pp.90148-90156, 1990. ,
Misprocessing of the CFTR protein leads to mild cystic fibrosis phenotype, Hum. Mutat, vol.25, pp.360-371, 2005. ,
Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation, Nature, vol.354, pp.526-528, 1991. ,
Particle mesh Ewald: an N · log(N) method for Ewald sums in large systems, J. Chem. Phys, vol.98, p.10089, 1993. ,
Abnormal localization of cystic fibrosis transmembrane conductance regulator in primary cultures of cystic fibrosis airway epithelia, J. Cell Biol, vol.118, pp.551-559, 1992. ,
Functional architecture of the cytoplasmic entrance to the cystic fibrosis transmembrane conductance regulator chloride channel pore, J. Biol. Chem, vol.290, pp.15855-15865, 2015. ,
A novel evaluation of residue and protein volumes by means of laguerre tessellation, J. Chem. Inf. Model, vol.50, pp.947-960, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00473943
Comparative analysis of threshold and tessellation methods for determining protein contacts, J. Chem. Inf. Model, vol.51, pp.493-507, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-00568174
Modulating the cystic fibrosis transmembrane regulator and the development of new precision drugs, Expert. Rev. Precis. Med. Drug Dev, vol.3, pp.357-370, 2018. ,
Optimization of the CHARMM additive force field for DNA: improved treatment of the BI/BII conformational equilibrium, J. Chem. Theory Comput, vol.8, pp.348-362, 2012. ,
Combining theoretical and experimental data to decipher CFTR 3D structures and functions, Cell. Mol. Life Sci, vol.75, pp.3829-3855, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02173807
An update on new and emerging therapies for cystic fibrosis, Expert. Opin. Emerg. Drugs, vol.22, pp.331-346, 2017. ,
Direct binding of the corrector VX-809 to human CFTR NBD1: evidence of an allosteric coupling between the binding site and the NBD1:CL4 Interface, Mol. Pharmacol, vol.92, pp.124-135, 2017. ,
cAMP-independent activation of CFTR Cl channels by the tyrosine kinase inhibitor genistein, Am. J. Physiol. Cell Physiol, vol.268, issue.4, pp.886-893, 1995. ,
CHARMM-GUI: a web-based graphical user interface for CHARMM, J. Comput. Chem, vol.29, pp.1859-1865, 2008. ,
Mutation analysis of ten exons of the CFTR gene in Greek cystic fibrosis patients: characterization of 74.5% of CF alleles including one novel mutation, Hum. Genet, vol.96, pp.364-366, 1995. ,
Mutation specific therapy in CF, Paediatr. Respir. Rev, vol.7, pp.166-169, 2006. ,
Localization studies of rare missense mutations in cystic fibrosis transmembrane conductance regulator (CFTR) facilitate interpretation of genotype-phenotype relationships, Hum. Mutat, vol.29, pp.1364-1372, 2008. ,
Correctors of the major cystic fibrosis mutant interact through membrane-spanning domains S, Mol. Pharmacol, vol.93, pp.612-618, 2018. ,
CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 additive force field, J. Chem. Theory Comput, vol.12, pp.405-413, 2016. ,
Molecular structure of the human CFTR Ion channel, Cell, vol.169, pp.85-92, 2017. ,
The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells, J. Biol. Chem, vol.268, pp.21592-21598, 1993. ,
Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin -induced intestinal fluid secretion, J. Clin. Invest, vol.110, pp.1651-1658, 2002. ,
Comprehensive mapping of cystic fibrosis mutations to CFTR protein identifies mutation clusters and molecular docking predicts corrector binding site, Proteins Struct. Funct. Bioinforma, vol.86, pp.833-843, 2018. ,
Fullopen and closed CFTR channels, with lateral tunnels from the cytoplasm and an alternative position of the F508 region, as revealed by molecular dynamics, Cell. Mol. Life Sci, vol.72, pp.1377-1403, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01134215
Membrane trafficking of the cystic fibrosis gene product, cystic fibrosis transmembrane conductance regulator, tagged with green fluorescent protein in madin-darby canine kidney cells, J. Biol. Chem, vol.273, pp.21759-21768, 1998. ,
Peripheral protein quality control removes unfolded CFTR from the plasma membrane, Science, vol.329, pp.805-810, 2010. ,
Mechanism-based corrector combination restores (F508-CFTR folding and function, Nat. Chem. Biol, vol.9, pp.444-454, 2013. ,
UCSF Chimera -A visualization system for exploratory research and analysis, J. Comput. Chem, vol.25, pp.1605-1612, 2004. ,
Scalable molecular dynamics with NAMD, J. Comput. Chem, vol.26, pp.1781-1802, 2005. ,
VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1, Mol. Biol. Cell, vol.24, pp.3016-3024, 2013. ,
Cystic Fibrosis, N. Engl. J. Med, vol.352, 1992. ,
Analysis of cystic fibrosis-associated P67L CFTR illustrates barriers to personalized therapeutics for orphan diseases, JCI Insight, vol.1, p.86581, 2016. ,
Tryptophan-lipid interactions in membrane protein folding probed by ultraviolet resonance Raman and fluorescence spectroscopy, Biophys. J, vol.100, pp.2121-2130, 2011. ,
Function, pharmacological correction and maturation of new Indian CFTR gene mutations, J. Cyst. Fibros, vol.14, pp.34-41, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01099879
Spectrum of mutations in the CFTR Gene of patients with classical and atypical forms of cystic fibrosis from southwestern sweden: identification of 12 novel mutations, Genet. Test, vol.5, pp.235-242, 2001. ,
Interhelical hydrogen bonds in the CFTR membrane domain, Nat. Struct. Biol, vol.8, pp.597-601, 2001. ,
Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function, J. Cyst. Fibros, vol.13, pp.29-36, 2014. ,
Characterization of 19 disease-associated missense mutations in the regulatory domain of the cystic fibrosis transmembrane conductance regulator, Hum. Mol. Genet, vol.7, pp.1761-1769, 1998. ,
From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations, Mol. Biol. Cell, vol.27, pp.424-433, 2016. ,
CHARMM-GUI membrane builder toward realistic biological membrane simulations, J. Comput. Chem, vol.35, 1997. ,
The preference of tryptophan for membrane interfaces, Biochemistry, vol.37, pp.14713-14718, 1998. ,
Atomic structure of the cystic fibrosis transmembrane conductance regulator, Cell, vol.167, 2016. ,
Conformational changes of CFTR upon phosphorylation and ATP binding, Cell, vol.170, 2017. ,
Molecular structure of the ATP-bound, phosphorylated human CFTR, Proc. Natl. Acad. Sci. U.S.A, vol.115, pp.12757-12762, 2018. ,